Related Experiment Videos
C-reactive protein: a 'golden marker' for inflammation and coronary artery disease
V B Patel1, M A Robbins, E J Topol
1Mid America Heart Institute, Saint Luke's Hospital, Kansas City, MO 64111, USA. vpatel@saint-lukes.org
Cleveland Clinic Journal of Medicine
|June 19, 2001
Insights
Elevated C-reactive protein (CRP) levels indicate higher cardiovascular risk. Measuring CRP can help identify at-risk patients for better clinical management and preventative strategies.
Area of Science:
- Biomedical Science
- Clinical Medicine
- Cardiology
Background:
- Elevated C-reactive protein (CRP) is a known biomarker for inflammation.
- Numerous studies link increased CRP levels to heightened cardiovascular risk.
Purpose of the Study:
- To advocate for increased utilization of CRP measurements in routine clinical practice.
- To highlight the role of CRP in identifying patients at elevated risk for cardiovascular events.
Main Methods:
- Review of existing scientific literature on CRP and cardiovascular disease.
- Analysis of the clinical implications of CRP levels in diverse patient populations.
Main Results:
- Consistent association between elevated CRP and increased cardiovascular risk across multiple studies.
- CRP serves as a valuable tool for risk stratification in various clinical scenarios.
Conclusions:
- Greater clinical adoption of CRP testing is recommended.
- CRP measurements can significantly aid in the early identification and management of high-risk cardiovascular patients.
Abstract:
Numerous studies have shown that elevated levels of C-reactive protein (CRP) are associated with increased cardiovascular risk. We advocate greater use of CRP measurements in clinical practice to identify patients at high risk in a variety of situations.